Internal Medicine, Pulmonary Disease · Los Angeles, CA
NPI
1912959925
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5901 W Olympic Blvd, Ste 200
Los Angeles, CA, 90036
Phone (323) 954-1788
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
43,463 services
Medicare patients, 2024
1,713
Average age 74
Drug cost, 2024
$4.6M
17,746 prescriptions
Company payments, 2025
$21K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abraham M Ishaaya was code 95004 (test - miscellaneous), 4,912 times for 57 patients. In total Abraham M Ishaaya billed 43,463 services in 120 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 4,912 | 57 | $3.25 | $16K |
| 99308 SNF E&M | Facility | 3,346 | 84 | $62.92 | $211K |
| 99232 Hospital E&M - Subsequent | Facility | 2,324 | 508 | $65.54 | $152K |
| 99233 Hospital E&M - Subsequent | Facility | 1,325 | 278 | $98.63 | $131K |
| 99214 Office E&M - Established | Office | 1,145 | 571 | $99.61 | $114K |
| 36415 Venipuncture Blood Collection | Office | 1,071 | 430 | $8.65 | $9,264 |
| 99213 Office E&M - Established | Office | 975 | 508 | $75.65 | $74K |
| 85025 Blood Count | Office | 717 | 318 | $7.61 | $5,456 |
| 84450 Clinical Chemistry | Office | 709 | 312 | $5.08 | $3,602 |
| 82150 Clinical Chemistry | Office | 709 | 312 | $6.35 | $4,502 |
| 82247 Clinical Chemistry | Office | 709 | 312 | $4.92 | $3,488 |
| 84075 Clinical Chemistry | Office | 708 | 312 | $5.08 | $3,597 |
| 82310 Clinical Chemistry | Office | 708 | 312 | $5.06 | $3,582 |
| 82565 Clinical Chemistry | Office | 708 | 312 | $5.02 | $3,554 |
| 84155 Clinical Chemistry | Office | 708 | 312 | $3.60 | $2,549 |
By year: 2022 $1.3M for 41,937 services; 2023 $1.4M for 40,326 services; 2024 $1.6M for 43,463 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,071 | 430 | $8.65 | $9,264 |
| 85025 Blood Count | 717 | 318 | $7.61 | $5,456 |
| 82150 Clinical Chemistry | 709 | 312 | $6.35 | $4,502 |
| 84450 Clinical Chemistry | 709 | 312 | $5.08 | $3,602 |
| 82247 Clinical Chemistry | 709 | 312 | $4.92 | $3,488 |
| 84155 Clinical Chemistry | 708 | 312 | $3.60 | $2,549 |
| 82310 Clinical Chemistry | 708 | 312 | $5.06 | $3,582 |
| 82565 Clinical Chemistry | 708 | 312 | $5.02 | $3,554 |
| 84075 Clinical Chemistry | 708 | 312 | $5.08 | $3,597 |
| 84460 Clinical Chemistry | 707 | 312 | $5.19 | $3,669 |
Medicare prescription drug claims, 2024
In 2024, the drug Abraham M Ishaaya prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 601 prescriptions and refills. In total Abraham M Ishaaya wrote 17,746 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 601 | 616 | 156 | $19K |
| Amlodipine Besylate Generic | 496 | 743 | 90 | $2,419 |
| Fluticasone Propionate Generic | 488 | 635 | 135 | $5,090 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 446 | 488 | 81 | $302K |
| Azelastine Hcl Generic | 440 | 510 | 127 | $9,369 |
| Atorvastatin Calcium Generic | 362 | 601 | 83 | $2,694 |
| Levetiracetam Generic | 311 | 328 | 34 | $10K |
| Eliquis Apixaban | 309 | 317 | 38 | $142K |
| Montelukast Sodium Generic | 288 | 431 | 61 | $1,314 |
| Ipratropium-Albuterol Ipratropium/Albuterol Sulfate | 287 | 287 | 44 | $5,765 |
| Gabapentin Generic | 267 | 315 | 48 | $5,073 |
| Ventolin Hfa Albuterol Sulfate | 266 | 269 | 50 | $16K |
| Rosuvastatin Calcium Generic | 264 | 457 | 52 | $3,113 |
| Losartan Potassium Generic | 256 | 470 | 52 | $1,503 |
| Chlorhexidine Gluconate Generic | 253 | 254 | 35 | $2,701 |
Brand drugs: 5,222 claims; generic drugs: 12,464 claims; opioid claims: 250.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abraham M Ishaaya $21K ($21K in general payments such as food, travel and fees) from 26 companies. The largest payer was Genzyme Corporation with $18K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 12 | $18K |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $599 |
| Insmed, Inc. INSM | 12 | $359 |
| Electromed, Inc. ELMD | 26 | $294 |
| Verona Pharma, Inc. VRNA | 15 | $285 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $271 |
| Harmony Biosciences LLC HRMY | 11 | $250 |
| Amgen Inc. AMGN | 9 | $161 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $109 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.